PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16111170-3	2005	PROCEDURE: Selectivity of firocoxib for inhibiting COX-2 was determined by comparing the potency for inhibiting COX-1 with that of COX-2 in feline blood.	firocoxib	26-35	cytochrome c oxidase subunit II	Felis catus	51-56	
16111170-3	2005	PROCEDURE: Selectivity of firocoxib for inhibiting COX-2 was determined by comparing the potency for inhibiting COX-1 with that of COX-2 in feline blood.	firocoxib	26-35	cytochrome c oxidase subunit II	Felis catus	131-136	
16111170-10	2005	CONCLUSIONS AND CLINICAL RELEVANCE: Firocoxib is a potent COX-2 inhibitor and is the only selective COX-2 inhibitor described for use in cats to date.	firocoxib	36-45	cytochrome c oxidase subunit II	Felis catus	58-63	
16111170-10	2005	CONCLUSIONS AND CLINICAL RELEVANCE: Firocoxib is a potent COX-2 inhibitor and is the only selective COX-2 inhibitor described for use in cats to date.	firocoxib	36-45	cytochrome c oxidase subunit II	Felis catus	100-105